access

News

First drug backed for NHS use in untreated Hodgkin lymphoma

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma.

News

Pharma furious as UK Statutory Scheme rebate rate soars

The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

Market Access

DNA Molecular Genetic Science Biotechnology

Overcoming barriers for global CGT adoption

Cell and gene therapies (CGT) have emerged as the next big thing in medicine, holding the power to deliver cures where none previously existed.

News

Lyfegen partners EVERSANA on pricing, access resource

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.

News

ADHD written all over a black background multiple times

Study finds big life expectancy deficit in adults with ADHD

UK study finds adults with ADHD have a big shortfall in life expectancy, raising questions about diagnosis rates and treatment access.

First drug backed for NHS use in untreated Hodgkin lymphoma

Pharma furious as UK Statutory Scheme rebate rate soars

Life Sciences Industry Report - Biologics and Generics

Overcoming barriers for global CGT adoption

Lyfegen partners EVERSANA on pricing, access resource

Study finds big life expectancy deficit in adults with ADHD

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

access

Editor's Picks